DOCSLIB.ORG

Retrograde Inhibition by a Specific Subset of Interpeduncular Α5 Nicotinic Neurons Regulates Nicotine Preference

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Retrograde Inhibition by a Specific Subset of Interpeduncular Α5 Nicotinic Neurons Regulates Nicotine Preference Retrograde inhibition by a specific subset of interpeduncular α5 nicotinic neurons regulates nicotine preference Jessica L. Ablesa,b,c, Andreas Görlicha,1, Beatriz Antolin-Fontesa,2,CuidongWanga, Sylvia M. Lipforda, Michael H. Riada, Jing Rend,e,3,FeiHud,e,4,MinminLuod,e,PaulJ.Kennyc, Nathaniel Heintza,f,5, and Ines Ibañez-Tallona,5 aLaboratory of Molecular Biology, The Rockefeller University, New York, NY 10065; bDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029; cDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029; dNational Institute of Biological Sciences, Beijing 102206, China; eSchool of Life Sciences, Tsinghua University, Beijing 100084, China; and fHoward Hughes Medical Institute, The Rockefeller University, New York, NY 10065 Contributed by Nathaniel Heintz, October 23, 2017 (sent for review October 5, 2017; reviewed by Jean-Pierre Changeux and Lorna W. Role) Repeated exposure to drugs of abuse can produce adaptive changes nicotine withdrawal, and optical activation of IPN GABAergic cells that lead to the establishment of dependence. It has been shown that is sufficient to produce a withdrawal syndrome, while blockade of allelic variation in the α5 nicotinic acetylcholine receptor (nAChR) gene GABAergic cells in the IPN reduced symptoms of withdrawal (17). CHRNA5 is associated with higher risk of tobacco dependence. In the Taken together these studies highlight the critical role of α5in brain, α5-containing nAChRs are expressed at very high levels in the regulating behavioral responses to nicotine. Here we characterize two subpopulations of GABAergic interpeduncular nucleus (IPN). Here we identified two nonoverlapping Amigo1 Epyc α + α Amigo1 α Epyc neurons in the IPN that express α5: α5- and α5- neu- 5 cell populations ( 5- and 5- ) in mouse IPN that respond α Amigo1 α Epyc differentially to nicotine. Chronic nicotine treatment altered the trans- rons. The translational profile of 5- cells, but not 5- , lational profile of more than 1,000 genes in α5-Amigo1 neurons, includ- shows enrichment for Nos1 and Sst. While the presence of strong neuronal nitric oxide synthase (NOS1) expression in the IPN has ing neuronal nitric oxide synthase (Nos1) and somatostatin (Sst). In been reported in cells that project to the dorsal raphe (DR) (18), contrast, expression of few genes was altered in the α5-Epyc popula- no studies have been conducted to determine its function in IPN NEUROSCIENCE tion. We show that both nitric oxide and SST suppress optically evoked circuitry. Here, we show that the α5-Amigo1 population utilizes neurotransmitter release from the terminals of habenular (Hb) neu- nitric oxide (NO) and somatostatin (SST) to provide retrograde rons in IPN. Moreover, in vivo silencing of neurotransmitter release Amigo1 Epyc inhibition of excitatory inputs from the MHb to the IPN. Con- from the α5- but not from the α5- population eliminates sistent with this retrograde mechanism, MHb neurons are nicotine reward, measured using place preference. This loss of nicotine enriched with the receptors for NO (soluble guanylyl cyclases) reward was mimicked by shRNA-mediated knockdown of Nos1 in the and with SST receptors. We demonstrate that α5-Amigo1 neurons IPN. These findings reveal a proaddiction adaptive response to chronic α + nicotine in which nitric oxide and SST are released by a specific 5 Significance neuronal population to provide retrograde inhibition of the Hb-IPN circuit and thereby enhance the motivational properties of nicotine. The CHRNA5-A3-B4 gene cluster, which encodes the α5, α3, and β4 nicotinic acetylcholine receptor subunits, has been ge- nicotine | interpeduncular nucleus | retrograde | α5 nicotinic netically associated with high risk of developing nicotine de- pendence. Here we show that a specific α5 nicotinic receptor he interpeduncular nucleus (IPN) is a single midline nucleus population in the midbrain interpeduncular nucleus (IPN) re- Tbeneath the ventral tegmental area that receives the majority sponds to chronic nicotine by increasing the expression of of its input from the medial habenula (MHb) and is reciprocally genes that regulate feedback inhibition of the medial habe- connected to the raphe nuclei (1–3). Recent evidence has high- nula, the major source of input to the IPN. Inhibiting neuro- + lighted a role of the IPN in nicotine consumption and withdrawal transmitter release from this population of α5 neurons or due to its high expression of the α5 nicotinic acetylcholine re- reducing expression of one of these genes, Nos1, blocks the ceptor (nAChR) subunit gene, the allelic variation in which is rewarding effects of nicotine. Our data identify molecular linked to increased risk of nicotine dependence (4–9). mechanisms that may explain the genetic link between The α5 subunit is considered an accessory component of func- CHRNA5 and smoking predisposition in humans. tional nAChRs, active only when combined with both α-and β-nAChR subunits (8, 10). Incorporation of α5 to heteromeric Author contributions: J.L.A., A.G., M.L., P.J.K., N.H., and I.I.-T. designed research; J.L.A., nAChRs channels potently increases their sensitivity to nicotine (8). A.G., B.A.-F., C.W., S.M.L., M.H.R., J.R., and F.H. performed research; M.L., P.J.K., N.H., and Mice with a null mutation of the Chrna5 gene self-administer more I.I.-T. contributed new reagents/analytic tools; J.L.A., A.G., B.A.-F., M.H.R., J.R., F.H., M.L., nicotine at higher, aversive doses, while reexpression of α5inthe N.H., and I.I.-T. analyzed data; and J.L.A., N.H., and I.I.-T. wrote the paper. MHb of α5 KO mice restored nicotine self-administration to wild- Reviewers: J.-P.C., CNRS, Institut Pasteur; and L.W.R., Stony Brook University. type (WT) levels, suggesting that α5 functions to limit nicotine intake The authors declare no conflict of interest. (6). Viral-mediated expression of the most common genetic variant Published under the PNAS license. in CHRNA5, found in heavy smokers, α5D398N, in the MHb of β4- 1Present address: Life Sciences 2: Microbiology, Immunology, Neurosciences, Deutsche overexpressing (Tabac) mice, which otherwise show enhanced Forschungsgemeinschaft, 53170 Bonn, Germany. aversion to nicotine, was sufficient to increase their nicotine intake to 2Present address: Clinical Sciences Centre, MRC London Institute of Medical Sciences, WT levels (7). α5 is also expressed in cortical interneurons, and mice Hammersmith Hospital Campus, London, W12 0NN, United Kingdom. expressing the human α5D398N variant exhibit neurocognitive be- 3Present address: Department of Neurobiology, Stanford University, Stanford, CA 94305. havioral deficits that resemble the hypofrontality observed in patients 4Present address: Department of Cellular and Molecular Biology, Division of Neurobiol- with schizophrenia and addiction (9). α5 has also been implicated in ogy, University of California, Berkeley, CA 94720. – nicotine withdrawal (11 13), characterized by somatic and affective 5To whom correspondence may be addressed. Email: [email protected] or iibanez@ symptoms, including increased anxiety (14, 15). Reexposure to nic- rockefeller.edu. otine during withdrawal increases intrinsic pacemaking activity of This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. MHb cholinergic neurons (16). IPN neurons are activated during 1073/pnas.1717506114/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1717506114 PNAS Early Edition | 1of6 Downloaded by guest on September 30, 2021 increase their production of NO and SST in response to chronic profile is unique to the IPN and differs significantly from cholin- nicotine, providing greater feedback inhibition onto MHb inputs. ergic MHb neurons (Fig. 1D and Datasets S1 and S3–S5). Consis- + This action serves to limit the release of habenula-derived glu- tent with existing data (17, 18), we found that α5 cells were also tamate and enhances the motivational properties of nicotine. enriched in Sst and Nos1; however, the α5-Amigo1 population was These results reveal a critical role for the α5-Amigo1 population of more highly enriched for these two transcripts than the α5-Epyc IPN cells in regulating the rewarding properties of nicotine population (Fig. 1D). MHb ChAT neurons express the receptors for through feedback inhibition of MHb inputs. Furthermore, our both neurotransmitters at higher levels than IPN neurons (Sstr2 and findings suggest that adaptive responses in this α5-Amigo1 con- Sstr4, Gucy1b3 and Gucy1a3)(Fig.1D). High expression of these trolled molecular circuitry likely plays an important role in reg- and other enriched TRAP-translated mRNAs in the two IPN ulating the development of nicotine dependence. populations matched the in situ hybridization signal of mRNA transcripts in the Allen Brain Atlas (Fig. S2). Analysis of the three Results populations revealed a great deal of similarity among them (Fig. α5-Expressing Neurons Can Be Subdivided into Two Populations. 1E), although the profiles for α5-Amigo1 and α5-Epyc indicate that Using translating ribosomal affinity profiling (TRAP) (19) com- these are distinct subpopulations of α5-expressing IPN neurons. bined with RNA sequencing (RNA-Seq), we set out to determine which genes were being actively translated by discrete pop- α5-Amigo1 and α5-Epyc Cells Are Two Nonoverlapping Populations with + ulations of α5 cells in the IPN using Chrna5-Cre mice crossed to Complementary Distribution in the IPN. To determine the distri- ribosome-tagged EGFP-L10a mice (Fig. 1A). In Chrna5-Cre bution of the two subpopulations, we employed Cre-dependent mice, the Chrna5-Chrna3-Chrnb4 gene cluster was overexpressed adeno-associated virus (AAV)-DIO-EGFP-L10a to label nuclei, in IPN neurons (Fig. S1 and Datasets S1 and S2), which reduces AAV-DIO-ChR2-eYFP to label axons and dendrites, and AAV- the utility of these mice for investigating the behavioral actions of DIO-mCherry to label cell bodies and, to a lesser extent, dendrites nicotine, since increased nAChR levels in MHb/IPN are known to (Fig.
Load more

Recommended publications
  • Developmental Plasticity and Circuit Mechanisms of Dopamine-Modulated Aggression Darshini Mahadevia Submitted in Partial Fulfill
    Developmental plasticity and circuit mechanisms of dopamine-modulated aggression Darshini Mahadevia Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2018 © 2018 Darshini Mahadevia All rights reserved ABSTRACT Developmental plasticity and circuit mechanisms of dopamine-modulated aggression Darshini Mahadevia Aggression and violence pose a significant public health concern to society. Aggression is a highly conserved behavior that shares common biological correlates across species. While aggression developed as an evolutionary adaptation to competition, its untimely and uncontrolled expression is maladaptive and presents itself in a number of neuropsychiatric disorders. A mechanistic hypothesis for pathological aggression links aberrant behavior with heightened dopamine function. However, while dopamine hyper-activity is a neural correlate of aggression, the developmental aspects and circuit level contributions of dopaminergic signaling have not been elucidated. In this dissertation, I aim to address these questions regarding the specifics of dopamine function in a murine model of aggressive behavior. In chapter I, I provide a review of the literature that describes the current state of research on aggression. I describe the background elements that lay the foundation for experimental questions and original data presented in later chapters. I introduce, in detail, published studies that describe the clinical manifestation and epidemiological spread, the dominant categories, the anatomy and physiology, and the pharmacology of aggression, with a particular emphasis on the dopaminergic system. Finally, I describe instances of genetic and environmental risk factors impacting aggression, concluding with studies revealing an important role for interactions among genetics, environmental factors, and age in the development of aggression.
    [Show full text]
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • JAD 5478.Pdf
    JAD-05478; No of Pages 9 Journal of Affective Disorders xxx (2012) xxx–xxx Contents lists available at SciVerse ScienceDirect Journal of Affective Disorders journal homepage: www.elsevier.com/locate/jad Research report Association of TPH1, TPH2, and 5HTTLPR with PTSD and depressive symptoms Armen K. Goenjian a,b,e,⁎, Julia N. Bailey c,d, David P. Walling b, Alan M. Steinberg a, Devon Schmidt b, Uma Dandekar d, Ernest P. Noble e a UCLA/Duke University National Center for Child Traumatic Stress, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA), United States b Collaborative Neuroscience Network, Garden Grove, CA 92845, United States c Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA, United States d Epilepsy Genetics/Genomics Laboratories, VA GLAHS, Los Angeles, CA, United States e Alcohol Research Center, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, United States article info abstract Article history: Objective: To examine the potential contribution of the serotonin hydroxylase (TPH1 and Received 29 January 2012 TPH2) genes, and the serotonin transporter promoter polymorphism (5HTTLPR) to the unique Accepted 5 February 2012 and pleiotropic risk of PTSD symptoms and depressive symptoms. Available online xxxx Methods: Participants included 200 adults exposed to the 1988 Spitak earthquake from 12 multigenerational families (3 to 5 generations). Severity of trauma exposure, PTSD, and de- Keywords: pressive symptoms were assessed using standard psychometric instruments. Pedigree-based Genetics variance component analysis was used to assess the association between select genes and PTSD the phenotypes. Depression Results: After adjusting for age, sex, exposure and environmental variables, there was a signif- Tryptophan hydroxylase icant association of PTSD symptoms with the ‘t’ allele of TPH1 SNP rs2108977 (pb0.004), Serotonin transporter explaining 3% of the phenotypic variance.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Effects of TPH2 Gene Variation and Childhood Trauma on the Clinical
    Movement disorders J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2019-322636 on 23 June 2020. Downloaded from ORIGINAL RESEARCH Effects of TPH2 gene variation and childhood trauma on the clinical and circuit- level phenotype of functional movement disorders Primavera A Spagnolo ,1 Gina Norato,2 Carine W Maurer,3 David Goldman,4 Colin Hodgkinson,4 Silvina Horovitz,1 Mark Hallett 1 ► Additional material is ABSTRact known about the contribution of genetic factors to published online only. To view, Background Functional movement disorders (FMDs), the pathophysiology of FMD. please visit the journal online (http:// dx. doi. org/ 10. 1136/ part of the wide spectrum of functional neurological Several studies have indicated that positive jnnp- 2019- 322636). disorders (conversion disorders), are common and often family history for FMD is associated with increased associated with a poor prognosis. Nevertheless, little morbidity risk among family members.2 3 However, 1 Human Motor Control is known about their neurobiological underpinnings, large- scale genetic epidemiology studies (eg, twin- Section, Medical Neurology particularly with regard to the contribution of genetic based, family- based, adoption- based and other Branch, National Institute on Nuerological Disorders and factors. Because FMD and stress-related disorders share population-based studies), which have provided a Stroke, National Institutes of a common core of biobehavioural manifestations, we necessary first step in establishing heritability and Health, Bethesda, MD, USA investigated whether variants in stress-related genes exploring genetic interactions in several neuropsy- 2 Office of Biostatistics, National also contributed, directly and interactively with childhood chiatric disorders, have not yet been carried out in Institute on Neurological Disorders and Stroke, National trauma, to the clinical and circuit-level phenotypes of patients with FMD.
    [Show full text]
  • The Habenular G-Protein–Coupled Receptor 151 Regulates Synaptic Plasticity and Nicotine Intake
    The habenular G-protein–coupled receptor 151 regulates synaptic plasticity and nicotine intake Beatriz Antolin-Fontesa, Kun Lia, Jessica L. Ablesa,b,c, Michael H. Riada, Andreas Görlicha, Maya Williamsb, Cuidong Wanga, Sylvia M. Lipforda, Maria Daob, Jianxi Liud, Henrik Molinae, Nathaniel Heintza,1, Paul J. Kennyb,d, and Ines Ibañez-Tallona1 aLaboratory of Molecular Biology, The Rockefeller University, New York, NY 10065; bNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574; cDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574; dDepartment of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574; and eProteomics Resource Center, The Rockefeller University, New York, NY 10065 Contributed by Nathaniel Heintz, January 17, 2020 (sent for review September 22, 2019; reviewed by Ana Belén Elgoyhen and Gord Fishell) The habenula, an ancient small brain area in the epithalamus, domains corelease acetylcholine and glutamate, which activate densely expresses nicotinic acetylcholine receptors and is critical postsynaptic receptors via volume and wired transmission, re- for nicotine intake and aversion. As such, identification of spectively (10, 11). Some of the highest densities of nicotinic strategies to manipulate habenular activity may yield approaches acetylcholine receptors (nAChRs) in the brain are detected in the to treat nicotine addiction. Here we show that GPR151, an orphan MHb–IPN axis (12–15), especially of α5, α3, and β4nAChR G-protein–coupled receptor (GPCR) highly enriched in the habenula subunits. Little was known about the MHb in regulating the mo- of humans and rodents, is expressed at presynaptic membranes and tivational properties of nicotine until human genetics studies synaptic vesicles and associates with synaptic components control- established a strong association between genetic variants in the ling vesicle release and ion transport.
    [Show full text]
  • Lmmunohistochemical Localization of Neuronal Nicotinic Receptors in the Rodent Central Nervous System
    The Journal of Neuroscience, October 1987, 7(10): 3334-3342 lmmunohistochemical Localization of Neuronal Nicotinic Receptors in the Rodent Central Nervous System L. W. Swanson,1v2 D. M. Simmons, I12 P. J. Whiting,’ and J. Lindstrom’ ‘The Salk Institute for Biological Studies, and 2Howard Hughes Medical Institute, La Jolla, California 92037 The distribution of nicotinic acetylcholine receptors (AChR) are structurally unrelated (Kubo et al., 1986a, b) to nicotinic in the rat and mouse central nervous system has been ACh receptors (AChR, Noda et al., 1983a, b), which act by mapped in detail using monoclonal antibodies to receptors regulating directly the opening of a cation channel that is an purified from chicken and rat brain. Initial studies in the intrinsic component of the molecule. Furthermore, subtypes of chicken brain indicate that different neuronal AChRs are con- neuronal AChRs have been identified on the basis of pharma- tained in axonal projections to the optic lobe in the midbrain cological and structural properties (Whiting et al., 1987a). To from neurons in the lateral spiriform nucleus and from retinal understand the functional significanceof ACh in a particular ganglion cells. Monoclonal antibodies to the chicken and rat neural system, it is therefore necessaryto establishthe cellular brain AChRs also label apparently identical regions in all localization of ACh, and the cellular localization and type of major subdivisions of the central nervous system of rats and cholinergic receptor with which it interacts. Immunohistochem- mice, and this pattern is very similar to previous reports of istry provides a sensitive method for localizing cholinergic neu- 3H-nicotine binding, but quite different from that of a-bun- rons with antibodies to the synthetic enzyme choline acetyl- garotoxin binding.
    [Show full text]
  • Understanding the Molecular Mechanisms of Aggression in BALB/C and TPH2-Deficient Mice
    Understanding the molecular mechanisms of aggression in BALB/c and TPH2-deficient mice Citation for published version (APA): Gorlova, A. (2020). Understanding the molecular mechanisms of aggression in BALB/c and TPH2- deficient mice. OneBook.ru. https://doi.org/10.26481/dis.20200305ag Document status and date: Published: 01/01/2020 DOI: 10.26481/dis.20200305ag Document Version: Publisher's PDF, also known as Version of record Please check the document version of this publication: • A submitted manuscript is the version of the article upon submission and before peer-review. There can be important differences between the submitted version and the official published version of record. People interested in the research are advised to contact the author for the final version of the publication, or visit the DOI to the publisher's website. • The final author version and the galley proof are versions of the publication after peer review. • The final published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.
    [Show full text]
  • Nicotine Aversion Is Mediated by Gabaergic Interpeduncular Nucleus Inputs to Laterodorsal Tegmentum
    ARTICLE DOI: 10.1038/s41467-018-04654-2 OPEN Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum Shannon L. Wolfman1, Daniel F. Gill1, Fili Bogdanic2, Katie Long3, Ream Al-Hasani4, Jordan G. McCall4,5,6, Michael R. Bruchas5,6 & Daniel S. McGehee1,2 1234567890():,; Nicotine use can lead to dependence through complex processes that are regulated by both its rewarding and aversive effects. Recent studies show that aversive nicotine doses activate excitatory inputs to the interpeduncular nucleus (IPN) from the medial habenula (MHb), but the downstream targets of the IPN that mediate aversion are unknown. Here we show that IPN projections to the laterodorsal tegmentum (LDTg) are GABAergic using optoge- netics in tissue slices from mouse brain. Selective stimulation of these IPN axon terminals in LDTg in vivo elicits avoidance behavior, suggesting that these projections contribute to aversion. Nicotine modulates these synapses in a concentration-dependent manner, with strong enhancement only seen at higher concentrations that elicit aversive responses in behavioral tests. Optogenetic inhibition of the IPN–LDTg connection blocks nicotine condi- tioned place aversion, suggesting that the IPN–LDTg connection is a critical part of the circuitry that mediates the aversive effects of nicotine. 1 Committee on Neurobiology, University of Chicago, Chicago, IL 60637, USA. 2 Department of Anesthesia & Critical Care, University of Chicago, Chicago, IL 60637, USA. 3 Interdisciplinary Scientist Training Program, University of Chicago, Chicago, IL 60637, USA. 4 St. Louis College of Pharmacy, Center for Clinical Pharmacology and Division of Basic Research of the Department of Anesthesiology, Washington University School of Medicine, St.
    [Show full text]
  • Identification of a Novel Synaptic G Protein-Coupled Receptor Controlling Nicotine Dependence and Withdrawal
    Identification of a novel synaptic G protein-coupled receptor controlling nicotine dependence and withdrawal Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) Submitted to the Department of Biology, Chemistry and Pharmacy of the Freie Universität Berlin by Beatriz Antolin Fontes from Girona, Spain Berlin, March 2014 This work was carried out in the period from June 2010 until March 2014 under the supervision of Dr. Inés Ibañez-Tallon and Prof. Dr. Constance Scharff at the Max- Delbrück-Center for Molecular Medicine (MDC) in Berlin and at The Rockefeller University in New York. 1st Reviewer: Dr. Inés Ibañez-Tallon 2nd Reviewer: Prof. Dr. Constance Scharff Date of defense: 18.06.2014 Scientific Acknowledgments I would like to express my sincere gratitude to all the people who made this thesis possible: - My supervisor Dr. Inés Ibañez-Tallon: For your advice, support and supervision throughout the years. Thank you for believing in me from the first moment, for giving me the opportunity to do research in different outstanding environments and specially, for transmitting always motivation and inspiration. I could not wish for a better supervisor. - My supervisor Prof. Dr. Constance Scharff from the Freie Universität Berlin: For your supervision and advice. - Prof. Dr. Nathaniel Heintz: For your valuable support and for so many useful and constructive recommendations on this project. - My fellow lab members, both current and past: Dr. Silke Frahm-Barske, Dr. Marta Slimak, Dr. Jessica Ables, Dr. Andreas Görlich, Dr. Sebastian Auer, Branka Kampfrath, Cuidong Wang, Syed Shehab, Dr. Martin Laqua, Dr. Julio Santos-Torres, Susanne Wojtke, Monika Schwarz-Harsi, and all Prof.
    [Show full text]
  • Electronic Supplementary Material (ESI) for Metallomics
    Electronic Supplementary Material (ESI) for Metallomics. This journal is © The Royal Society of Chemistry 2018 Uniprot Entry name Gene names Protein names Predicted Pattern Number of Iron role EC number Subcellular Membrane Involvement in disease Gene ontology (biological process) Id iron ions location associated 1 P46952 3HAO_HUMAN HAAO 3-hydroxyanthranilate 3,4- H47-E53-H91 1 Fe cation Catalytic 1.13.11.6 Cytoplasm No NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis dioxygenase (EC 1.13.11.6) (3- [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; response to hydroxyanthranilate oxygenase) cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan (3-HAO) (3-hydroxyanthranilic catabolic process [GO:0006569] acid dioxygenase) (HAD) 2 O00767 ACOD_HUMAN SCD Acyl-CoA desaturase (EC H120-H125-H157-H161; 2 Fe cations Catalytic 1.14.19.1 Endoplasmic Yes long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty 1.14.19.1) (Delta(9)-desaturase) H160-H269-H298-H302 reticulum acid biosynthetic process [GO:0006636] (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) (hSCD1) 3 Q6ZNF0 ACP7_HUMAN ACP7 PAPL PAPL1 Acid phosphatase type 7 (EC D141-D170-Y173-H335 1 Fe cation Catalytic 3.1.3.2 Extracellular No 3.1.3.2) (Purple acid space phosphatase long form) 4 Q96SZ5 AEDO_HUMAN ADO C10orf22 2-aminoethanethiol dioxygenase H112-H114-H193 1 Fe cation Catalytic 1.13.11.19 Unknown No oxidation-reduction process [GO:0055114]; sulfur amino acid catabolic process (EC 1.13.11.19) (Cysteamine
    [Show full text]
  • G Protein-Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. British Journal of Pharmacology (2015) 172, 5744–5869 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors Stephen PH Alexander1, Anthony P Davenport2, Eamonn Kelly3, Neil Marrion3, John A Peters4, Helen E Benson5, Elena Faccenda5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5 and CGTP Collaborators 1School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, 2Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 5Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/ 10.1111/bph.13348/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading.
    [Show full text]